Hui Peng
- Co-authors
- Jian‐Ting ZhangZizheng DongJunkang XuJialin ZhengChunzheng YangShuangqing PengJing QiTong‐Chun Wen
- Topics
- Drug Transport and Resistance Mechanisms (8 papers)Cancer therapeutics and mechanisms (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Peng
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 617
- Oncology 407
- Cancer Research 131
- Immunology 93
- Cellular and Molecular Neuroscience 81
Countries citing papers authored by Hui Peng
This map shows the geographic impact of Hui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Peng more than expected).
Fields of papers citing papers by Hui Peng
This network shows the impact of papers produced by Hui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Peng. The network helps show where Hui Peng may publish in the future.
Co-authorship network of co-authors of Hui Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Peng. A scholar is included among the top collaborators of Hui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Peng. Hui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 37 | |
| 7 | 19 | |
| 8 | 24 | |
| 9 | Effect of Polysaccharides from Rehmanniue Radix on Oxidative Stress and Apoptosis of Neonatal Rat Cardiomyocytes Impaired by Hypoxia-Reoxygenation | 1 |
| 10 | 33 | |
| 11 | 43 | |
| 12 | A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion | 2 |
| 13 | 29 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 20 | |
| 17 | 42 | |
| 18 | 31 | |
| 19 | 32 | |
| 20 | 50 |
About Hui Peng
Hui Peng is a scholar working on Oncology, Pharmacology and Molecular Biology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Cancer therapeutics and mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Developmental Neuroscience (64 citations), Oncology (407 citations) and Molecular Biology (617 citations). Hui Peng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jian‐Ting Zhang, Zizheng Dong, Junkang Xu, Jialin Zheng, Chunzheng Yang, Shuangqing Peng, Jing Qi, Tong‐Chun Wen, Jiabin Guo and Wei Huang. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.